A significant proportion of patients who suffer from atrial fibrillation (AF) and are in need of
thromboembolic protection are not treated with oral anticoagulation or discontinue this …

Importance Optimal antithrombotic therapy after percutaneous left atrial appendage
occlusion (LAAO) is not well established as no randomized evaluation has been performed …

Percutaneous transcatheter structural heart interventions have considerably expanded
within the last two decades, improving clinical outcomes and quality of life versus guideline …

Background The prevalence of and outcomes associated with different antithrombotic
strategies after left atrial appendage occlusion (LAAO) are not well described. Objectives …

Atrial fibrillation (AF) is the most common arrhythmia worldwide, and is associated with a
significant risk of thromboembolic events. Left atrial appendage occlusion (LAAO) has …

Many patients with atrial fibrillation (AF) who are in need of stroke prevention are not treated
with oral anticoagulation or discontinue treatment shortly after its initiation. Despite the …

Background Patients treated with left atrial appendage occlusion (LAAO) are at high
bleeding risk. Intensive antithrombotic treatment is recommended after the procedure to …

Background In the last few years, percutaneous LAA occlusion (LAAO) has become a
plausible alternative in atrial fibrillation (AF) patients with contraindications to …

Left atrial appendage occlusion (LAAO) is an established alternative to oral anticoagulation
for stroke prevention in atrial fibrillation. Antithrombotic therapy is used in the post …

Introduction The prevalence of atrial fibrillation (AF) is increasing globally, and stroke
prevention is the key to reduce the morbidity and mortality related to AF. Currently, direct oral …